[PDF] Top 20 Association of menopausal status, expression of progesterone receptor and Ki67 to the clinical response to neoadjuvant chemotherapy in luminal breast cancer
Has 10000 "Association of menopausal status, expression of progesterone receptor and Ki67 to the clinical response to neoadjuvant chemotherapy in luminal breast cancer" found on our website. Below are the top 20 most common "Association of menopausal status, expression of progesterone receptor and Ki67 to the clinical response to neoadjuvant chemotherapy in luminal breast cancer".
Association of menopausal status, expression of progesterone receptor and Ki67 to the clinical response to neoadjuvant chemotherapy in luminal breast cancer
... likely to achieve cCR. In several studies, young age at diagnosis was identi fied as an independent predictor of recurrence and mortality in breast cancer ...23,24 ... See full document
9
Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study.
... 1999 to December 2011, a total of 655 consecutive patients with operable or locally advanced breast cancer who received NCT at Cancer Hospital, Chinese Academy of Medical ... See full document
13
Cyclooxygenase-2 immunoexpression in breast cancer : progesterone receptor influence
... COX-2 and PR immunostaining only in ductal invasive breast cancer in patients not submitted to primary chemotherapy, radiotherapy or hormone ...therapy. In our ... See full document
90
Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assay.
... value of Ki67 in assessing neoadjuvant response has recently been demonstrated by Dowsett et ...with the aromatase inhibitor anastrozole was more effective in reducing ... See full document
8
Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
... localized breast cancer who underwent NAC and had non-pCR carcinoma in surgical specimen between 01/01/2013 to 12/31/2015 with a three-year ...estimator and hazard ratio (HR) set ... See full document
13
Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy
... Breast cancer is a complex disease, with heterogeneous clinical ...performed to identify the risk factors for breast cancer progression and the patients who ... See full document
9
Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer
... Objective: To define a predictive factor for pathologic complete response, compare the oncologic outcomes associated with the degree of pathologic response after ... See full document
7
Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
... Oestrogen and oestrogen receptors (ERs) play key roles in both normal breast development and breast cancer ...ER expression is a prognostic factor and powerful ... See full document
12
The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation.
... from the Breast Malignancy Database established by the Department of Surgery, Shanghai Cancer Center of Fudan University in Shanghai, ...(CNB) of large operable or ... See full document
7
Preditores de resposta à quimioterapia neoadjuvante em pacientes com carcinoma luminal de mama = Predictors of response to neoadjuvant chemotherapy in patients with luminal breast cancer
... with luminal A-like tumors presented PCR, while the rates were ...(4/76) and 12.9% (4/31) for luminal B-like (HER2-negative) and luminal B-like (HER2-positive), ...respectively. ... See full document
83
Association of PKCζ expression with clinicopathological characteristics of breast cancer.
... linked to cancer. It has been suggested that atypical PKCs contribute to cell proliferation and cancer ...respect to breast cancer, PKCf has been found to ... See full document
6
Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.
... basal breast cancer MDA-MB- 231 cell line (PR - , ERα - ) (American Type Culture Collection, Manassas, VA, USA) as previ- ously described ...PRA and/or PRB expression could be induced at will ... See full document
19
Neoadjuvant Radiotherapy and Hormonotherapy in Locally Advanced Breast Cancer: State of the Art
... (estudos in vitro, in vivo em animais e estudos ...estudos in vitro, que ainda não foi confirmada nem nos estudos in vivo em animais nem nos ...ductal in situ assim como no carcinoma ... See full document
5
Thyroid hormone status interferes with estrogen target gene expression in breast cancer samples in menopausal women
... utilized to evaluate gene expression modified by T3 or E2 treatment and produced similar but not identical results to those observed in breast cancer cell ...but ... See full document
9
Fatores prognósticos e preditivos da resposta clínica e patológica em mulheres com carcinoma de mama submetidas a quimioterapia neoadjuvante = Prognostic and predictive factors of the clinical and pathological response in women with breast carcinoma submitted to neoadjuvant chemotherapy
... Para o objetivo específico 1, a RPc, a RCc e a relação entre a RPc e a RCc foram consideradas como desfechos principais. A análise estatística bivariada avaliou a associação entre variáveis categóricas independentes e a ... See full document
125
Clinical significance of miR-140-5p and miR-193b expression in patients with breast cancer and relationship to IGFBP5
... role of IGFBP5 in breast cancer is ...Experimental and bioinformatics studies have shown that IGFBP5 is targeted by miR-140-5p and miR-193b, although this has not yet been proven ... See full document
9
The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
... NAC in patients with MIBC and the outcomes of randomised trials, the rate of patients receiving NAC has seen little ...increase. The reason for this low rate might be due ... See full document
6
New insight into Ki67 expression at the invasive front in breast cancer.
... thickness of 4 mm using a cryostat. The sections were mounted on microscope slides, air dried, and then fixed in a mixture of 50% acetone and 50% ...methanol. The sections ... See full document
5
Androgen receptor expression in triple-negative breast cancer
... conditions, the human body produces various types of hormones responsible, for example, by the growth of several types of ...One of these hormones is estrogen which is ... See full document
80
Gene expression profiling of clinical stages II and III breast cancer
... Invasive breast cancer was confirmed his- topathologically in samples obtained by core or incisional ...biopsy. Clinical staging included physical examination with inspection and pal- ... See full document
13
temas relacionados